Skip to main content
. 2020 Dec 25;10(1):42. doi: 10.3390/jcm10010042

Figure 5.

Figure 5

HLA-E and killer cell Ig-like receptor (KIR) genotyping in different groups of patients with CML. (A) Analysis by qPCR of the percentage of HLA-E genotyping and alleles frequency in patients with CML who relapsed during treatment interruption (n = 13) in comparison with patients with CML who did not relapse (n = 24). (B) Analysis of the percentage of KIR alleles and haplotypes frequency was performed in patients with CML who relapsed during treatment interruption (n = 7) or not (Off TKI) (n = 8). Each dot corresponds to one sample and lines represent mean ± SEM. Statistical significance was calculated using one-way ANOVA and Tukey’s multiple comparisons test. * p < 0.05.